• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    ARCA biopharma, Inc. (ABIO)

    -NasdaqCM
    0.71 0.00(0.00%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:0.71
    Open:0.70
    Bid:0.63 x 400
    Ask:N/A
    1y Target Est:3.75
    Beta:3.11
    Next Earnings Date:N/A
    Day's Range:0.70 - 0.74
    52wk Range:0.69 - 2.38
    Volume:130,627
    Avg Vol (3m):336,169
    Market Cap:15.02M
    P/E (ttm):N/A
    EPS (ttm):-0.52
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ABIO

    Comparison

    Symbol% ChgMkt Cap
    ABIO 0.00%15.02M
    AZNDown 1.18%89.72B
    GSKDown 2.57%105.78B
    ILIUDown 2.58%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatm... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback